Blood disorders
Multiple myeloma in Changchun
长春 多发性骨髓瘤
3 hospitals in Changchun
Order: papers led on multiple myeloma, 2021–2025, then A–Z. Research activity, not a rating of care.
Only hospitals listed for multiple myeloma: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Changchun may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.
- 17 papers led
- 4 papers ledNo open trial led
- 4 papers ledNo open trial led
Multiple myeloma in every city Changchun on the disease page, with the national map
open trials on multiple myeloma with a hospital in Changchun
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 8 Nov 2026, with a listed hospital in Changchun as lead sponsor or study site. 4 of them are led by a hospital in Changchun. Check the registry for the current status. Whether someone can take part is decided by the study team.
Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.
- RecruitingA Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Phase
- Phase 3
- Started
- 2026-05
- Registry
- NCT07518186
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 14 listed hospitals as study sitesBeijing, Changchun, Chengdu, Hangzhou, Nanchang, Nanjing, Shenzhen, Tianjin, Wenzhou, Wuhan, Xi'an
- Recruiting68Ga-BCMA PET/CT in Multiple Myeloma
- Phase
- Phase 2/Phase 3
- Started
- 2025-12
- Registry
- NCT07319897
Age 18 years to 80 years (registered criteria)
Led by Peking University First Hospital; 2 listed hospitals as study sitesBeijing, Changchun, Shijiazhuang
- RecruitingIL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
- Phase
- Phase 2
- Started
- 2025-12
- Registry
- NCT07509086
Age 18 years to 80 years (registered criteria)
Led by First Hospital of Jilin UniversityChangchun
- RecruitingA Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
- Phase
- Phase 1/Phase 2
- Started
- 2023-10
- Registry
- NCT06049290
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 19 listed hospitals as study sitesBeijing, Changchun, Guangzhou, Guiyang, Haikou, Hangzhou, Ningbo, Qingdao, Shanghai, Shenyang, Shenzhen, Suzhou, Taiyuan, Wenzhou, Wuhan, Xi'an, Xiamen, Zhengzhou
- RecruitingDara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
- Phase
- Not given
- Started
- 2023-06
- Registry
- NCT06252792
Age 18 years to Not stated (registered criteria)
Led by First Hospital of Jilin UniversityChangchun
- RecruitingPhase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
- Phase
- Phase 3
- Started
- 2022-09
- Registry
- NCT05243797
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 11 listed hospitals as study sitesBeijing, Changchun, Hangzhou, Jinan, Shanghai, Shenyang, Tianjin, Wenzhou, Wuhan, Zhengzhou
- RecruitingA Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Phase
- Phase 3
- Started
- 2022-10
- Registry
- NCT05552222
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 29 listed hospitals as study sitesBeijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Jinan, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shenzhen, Tianjin, Wenzhou, Wuhan, Xi'an, Xiamen, Zhengzhou
- RecruitingA Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
- Phase
- Phase 3
- Started
- 2022-11
- Registry
- NCT05623020
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 12 listed hospitals as study sitesBeijing, Changchun, Fuzhou, Guangzhou, Hangzhou, Nanjing, Shanghai, Suzhou, Tianjin, Wenzhou, Wuhan
- RecruitingA Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- Phase
- Phase 3
- Started
- 2021-10
- Registry
- NCT05020236
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 20 listed hospitals as study sitesBeijing, Changchun, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing, Shenzhen, Shijiazhuang, Tianjin, Wenzhou, Wuhan, Xuzhou, Zhengzhou
- RecruitingIndividualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM
- Phase
- Not given
- Started
- 2021-09
- Registry
- NCT06099912
Age 65 years to Not stated (registered criteria)
Led by First Hospital of Jilin UniversityChangchun
- Not yet recruitingRisk-adapted Therapeutic Strategy in +1q NDMM
- Phase
- Not given
- Started
- 2025-09
- Registry
- NCT07045168
Age not stated (registered criteria)
Led by First Hospital of Jilin UniversityChangchun
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Disease research in Changchun
Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.
A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.
| Cancer | Blood disorders | Other diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | Nasopharyngeal carcinoma | Oesophageal squamous cell carcinoma | Hepatocellular carcinoma | Stomach cancer | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Multiple myeloma | B-cell acute lymphoblastic leukaemia | Aplastic anaemia | Haemophagocytic lymphohistiocytosis | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | Neuromyelitis optica spectrum disorder | IgG4-related disease | Myasthenia gravis | Moyamoya disease | Wilson disease | Biliary atresia | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency | Shortlist |
| Affiliated Hospital of Changchun University of Chinese Medicine长春中医药大学附属医院 | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | 6 | none | none | none | none | none | none | 3 | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| China Japan Union Hospital吉林大学第三医院(中日联谊医院) | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| China-Japan Union Hospital, Jilin University吉林大学白求恩第三医院(中日联谊医院) | none | none | 20 | 21 | none | 0 | 0 | 13 | 1 | 1 | 0 | 4 | none | none | none | none | none | none | none | none | 3 | none | 2 | 2 | none | none | none | none | none | 1 | none | 1 | 0 | none | none | none | 0 | none | 0 | none | none | none | 1 | 1 | none | none | none | none | none | none | none | none | none | |
| First Affiliated Hospital, Changchun University of Chinese Medicine长春中医药大学附属医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | |
| First Hospital of Jilin University吉林大学第一医院 | 3 | 5 | 761 open | 417 open | 1 | 3 | 0 | 17 | 0 | 7 | 2 | 174 open | 0 | 2 | 4 | none | 0 | 2 | 1 | none | 11 | none | 1 | 4 | 2 | none | 5 | 2 | none | 1 | none | 2 | 0 | 1 | none | 0 | 3 | 0 | 71 open | 1 | none | 0 | 11 | 1 | none | none | none | none | 0 | none | none | none | none | |
| First Norman Bethune Hospital吉林大学第一医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Japan Union Hospital, Jilin University吉林大学第三医院(中日联谊医院) | none | none | none | none | none | 0 | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jilin Cancer Hospital吉林省肿瘤医院 | none | 0 | 4 | 0 | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jilin Province FAW General Hospital吉林省一汽总医院 | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jilin Province People's Hospital吉林省人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jilin Provincial People's Hospital吉林省人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jilin University Bethune Second Hospital吉林大学第二医院 | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jilin University Sino-Japanese Friendship Hospital吉林大学第三医院(中日联谊医院) | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Second Hospital of Jilin University吉林大学第二医院 | 0 | 1 | 15 | 17 | none | 1 | none | 10 | 1 | 1 | 0 | 4 | none | none | none | none | none | none | none | none | none | 5 | none | none | none | none | none | 0 | none | 7 | none | 2 | none | none | 1 | none | 1 | 0 | 7 | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | |
| Second Norman Bethune Hospital吉林大学第二医院 | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Third Hospital of Jilin University吉林大学第三医院(中日联谊医院) | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
Column labels are short names. Choose one to open that disease in Changchun.
- Hepatocellular carcinoma 20
- Stomach cancer 21
- Retinoblastoma 0
- Chordoma 0
- Osteosarcoma 13
- Gastrointestinal stromal tumour 1
- Neuroblastoma 1
- Ewing sarcoma 0
- Multiple myeloma 4
- Neuromyelitis optica spectrum disorder 3
- Myasthenia gravis 2
- Moyamoya disease 2
- Idiopathic pulmonary fibrosis 1
- Amyotrophic lateral sclerosis 1
- Spinal muscular atrophy 0
- Behçet disease 0
- IgA nephropathy 0
- Primary biliary cholangitis 1
- Primary sclerosing cholangitis 1
- Nasopharyngeal carcinoma 3
- Oesophageal squamous cell carcinoma 5
- Hepatocellular carcinoma 761 open
- Stomach cancer 417 open
- Hepatoblastoma 1
- Retinoblastoma 3
- Chordoma 0
- Osteosarcoma 17
- Gastrointestinal stromal tumour 0
- Neuroblastoma 7
- Ewing sarcoma 2
- Multiple myeloma 174 open
- B-cell acute lymphoblastic leukaemia 0
- Aplastic anaemia 2
- Haemophagocytic lymphohistiocytosis 4
- Haemophilia A 0
- Atypical haemolytic uraemic syndrome 2
- Thrombotic thrombocytopenic purpura 1
- Neuromyelitis optica spectrum disorder 11
- Myasthenia gravis 1
- Moyamoya disease 4
- Wilson disease 2
- Anti-NMDA receptor encephalitis 5
- Takayasu arteritis 2
- Idiopathic pulmonary fibrosis 1
- Amyotrophic lateral sclerosis 2
- Spinal muscular atrophy 0
- Fabry disease 1
- Duchenne muscular dystrophy 0
- Behçet disease 3
- Alport syndrome 0
- IgA nephropathy 71 open
- Gaucher disease 1
- Osteogenesis imperfecta 0
- Primary biliary cholangitis 11
- Primary sclerosing cholangitis 1
- Familial adenomatous polyposis 0
- Nasopharyngeal carcinoma 0
- Oesophageal squamous cell carcinoma 1
- Hepatocellular carcinoma 15
- Stomach cancer 17
- Retinoblastoma 1
- Osteosarcoma 10
- Gastrointestinal stromal tumour 1
- Neuroblastoma 1
- Ewing sarcoma 0
- Multiple myeloma 4
- IgG4-related disease 5
- Takayasu arteritis 0
- Idiopathic pulmonary fibrosis 7
- Amyotrophic lateral sclerosis 2
- Pompe disease 1
- Behçet disease 1
- Alport syndrome 0
- IgA nephropathy 7
- Primary biliary cholangitis 2
Other cities nearby
Straight-line distance from the city centre; counts are hospitals listed for multiple myeloma.
Counts are listed hospitals only, not every hospital in each city.
Where these numbers come from
Papers
English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions
Trials
ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Changchun on ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.